Ad
related to: norah o'donnell bio
Search results
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Zacks via Yahoo Finance· 7 hours agoBio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma...
Beverly Hills Private Wealth LLC Sells 170 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
ETF DAILY NEWS· 13 hours agoBeverly Hills Private Wealth LLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 15.7% during the 4th quarter, according ...
Why Palisade Bio Stock Is Soaring Today - Palisade Bio (NASDAQ:PALI)
Benzinga· 6 hours agoPalisade Bio, Inc. PALI shares are trading higher Tuesday after the company announced the completion...
Why Is Palisade Bio (PALI) Stock Up 57% Today?
InvestorPlace· 6 hours agoPalisade Bio (NASDAQ:PALI) stock is climbing higher on Tuesday after the clinical-stage biopharmaceutical company revealed additional data for its...
Mustang Bio stock tumbles 27% amid news of mass layoffs (NASDAQ:MBIO)
Seeking Alpha· 1 day agoMustang Bio (MBIO) stock tumbled 27% Monday in the wake of news that the company plans to cut around...
Nosh.bio sidesteps many challenges constraining alt-protein with a versatile mycoprotein and...
Food Navigator USA· 8 hours agoNosh.bio’s CEO recently told FoodNavigator-USA at Future Food-Tech in San Francisco that the...
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from...
Digital Journal· 11 hours agoThe combined offering will be ideal for mRNA drug developers who require discovery and optimization with in silico...
Third Harmonic Bio Inc CEO Natalie Holles Sells 13,558 Shares
GuruFocus.com via Yahoo Finance· 23 hours agoNatalie Holles, CEO of Third Harmonic Bio Inc (NASDAQ:THRD), has sold 13,558 shares of the company...
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The...
FOX 23 News Albany· 12 hours agoThe Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE). Shareholders who purchased shares of BLUE during the class period listed ...
Biotech cites federal review of deal with Chinese firm in latest staff cuts - Boston Business...
The Business Journals· 12 hours agoMustang Bio Inc. is cutting the majority of its team as it encounters a challenging fundraising environment and an ongoing federal government review of its deal to sell manufacturing ...
